查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1677264

碘化鈉 [131I] 市場按類型、產品形式、製造方法、應用和最終用途行業分類 - 2025 年至 2030 年全球預測

Sodium Iodide [131I] Market by Type, Form, Production Method, Application, End-Use Industry - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

碘化鈉 [131I] 市場預計在 2024 年達到 7.368 億美元，2025 年達到 7.7902 億美元，到 2030 年達到 10.4182 億美元，複合年成長率為 5.94%。

主要市場統計數據
基準年 2024 年 7.368億美元
預計 2025 年 7.7902億美元
預測年份 2030 10.4182億美元
複合年成長率（%） 5.94％

碘化鈉 [131I] 在現代核子醫學和工業應用中發揮關鍵作用，徹底改變了治療和診斷領域。隨著精準干預的需求不斷增加，這種放射性同位素已成為放射性藥物配方和各種研究舉措中的重要組成部分。技術和監管措施的最新進展增強了製造方法的可靠性，確保品質和安全符合最高的國際標準。

在當今的動態環境中，相關人員正在見證傳統方法與創新製造技術融合的轉變。碘化鈉 [131I] 的發展反映了行業的更廣泛趨勢：轉向更有效率、更安全和更具成本效益的方法，以支撐臨床卓越性和行業信譽。這項全面分析探討了碘化鈉 [131I] 在診斷影像、放射治療和科學研究中的多方面作用。每項發展都凸顯了技術整合和監管進步對於維持產業成長動能的重要性。

此外，對不斷變化的市場動態的洞察表明，將嚴格的品管與漸進式研究相結合的綜合方法可以顯著提高碘化鈉 [131I] 的生產和應用。本介紹性概述提供了瞭解後續市場區隔、區域趨勢和企業策略舉措分析所需的背景資訊。

生產、應用與市場動態的變化

在過去的幾年裡，碘化鈉 [131I] 市場經歷了變革性的變化，重塑了其生產和應用的模式。公司和研究機構迅速採用先進技術，使製造方法更加可靠和有效率。基於加速器和基於核子反應爐的技術創新大大縮短了生產時間，同時又不影響品質和安全。

這種轉變也體現在向個人化醫療的轉變，其中精確成像和標靶治療是關鍵。這種發展刺激了對尖端線性加速器和強子加速器的投資，它們在製造過程中發揮核心作用。同時，傳統的基於核子反應爐的生產方式也正在被重塑，迴旋加速器輻照反應器和鈾裂變反應器正在適應新的效率和安全標準。

這種轉變是由法律規範和日益增加的研究推動的，以不斷檢驗和改進操作通訊協定。市場正穩步從傳統方式轉向滿足臨床和工業要求的全面高科技解決方案。當今的情況反映出一個動態變化的時代，合作策略和技術進步推動著快速發展的核醫學和研究領域的創新和競爭優勢。

按生產、形式、應用和最終用途行業細分的見解

對碘化鈉 [131I] 市場的詳細細分分析揭示了其複雜的結構，可滿足生產、形式、應用和最終用途行業的多面性。首先，依類型分類，市場分為兩大類：純碘化鈉[131I]和放射性藥物。這種分類強調了產品的雙重性質，它既可以作為獨立元素，也可以作為多種治療程序的組成部分。

產品有多種形式，包括膠囊、液體和固體，每種形式都具有與易於管理、穩定性和劑量準確性相關的獨特優勢。產品形式對於確保滿足各種臨床和研究場所的特定要求至關重要。此外，製造方法也是一個重要的分割參數。該行業同時採用基於加速器和基於反應器的製造方式。基於加速器的方法正在透過強子和線性加速器等應用進一步完善，而基於核子反應爐的生產則利用迴旋加速器輻照和鈾裂變反應器。這些創新技術確保了製造的擴充性和對不斷發展的監管標準的適應性。

除了生產技術外，市場還根據應用進一步細分。在工業領域，它們服務於諸如輻射屏蔽和放射性示踪劑之類的小眾使用案例。另一方面，醫療產業是主要的消費者，尤其是在診斷影像、放射性藥物製造和治療程序方面。此外，化學合成和核子醫學研究的應用繼續推動市場擴張。最後，按最終用途行業細分突顯了這些產品的廣泛範圍，涵蓋學術和研究機構、化學和生物技術行業、醫療保健和製藥領域，甚至核能發電廠，反映了碘化鈉 [131I] 廣泛的市場範圍和多樣化的應用前景。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 碘化鈉 [131I] 在腫瘤個人化治療中的應用日益廣泛，推動了市場成長
      • 核子醫學和放射性藥物技術的進步將促進碘化鈉[131I]在診斷和治療中的應用。
      • 使用碘化鈉 [131I] 放射性碘療法治療甲狀腺癌的標靶癌症治療需求日益增加
    • 限制因素
      • 碘化鈉 [131I] 製造和處理的監管挑戰和嚴格的安全通訊協定限制了市場的成長
    • 機會
      • 增加碘化鈉[131I]的研發投入，以增​​強其治療應用並改善病患治療效果。
      • 針對罕見癌症的新型放射性碘治療方法的出現，為以碘為重點的 [131I] 市場參與者提供了新的成長途徑
    • 任務
      • 碘化鈉 [131I] 治療有潛在副作用，例如甲狀腺功能障礙和放射線暴露風險，會影響患者的接受度。
  • 市場區隔分析
    • 類型：碘化鈉[131I]在癌症治療和診斷放射性藥物中的作用
    • 最終用途產業：碘化鈉 [131I] 在化學和生物技術產業的藥物開發和分子影像中的重要性
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 經濟
    • 社會的
    • 技術的
    • 合法的
    • 環境

6. 碘化鈉[131I]市場依類型

  • 純碘化鈉[131I]
  • 放射性藥物

7. 碘化鈉[131I]市場（依形式）

  • 膠囊
  • 液體
  • 固體形式

8. 碘化鈉[131I]市場（依製造方法）

  • 基於加速器的生產
    • 強子對撞機
    • 線性加速器
  • 核子反應爐生產
    • 迴旋加速器輻照
    • 鈾裂變反應堆

9. 碘化鈉[131I]市場應用

  • 產業
    • 輻射屏蔽
    • 放射性示踪劑的應用
  • 藥品
    • 診斷影像
    • 放射性藥物製造
    • 治療程序
  • 調查
    • 化學合成
    • 核子醫學調查

10. 碘化鈉 [131I] 市場（依最終用途產業分類）

  • 學術和研究機構
  • 化學和生物技術產業
  • 醫療保健和製藥
  • 核能發電廠

11. 美國碘化鈉[131I]市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太地區碘化鈉 [131I] 市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲的碘化鈉[131I]市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章 競爭格局

  • 2024 年市場佔有率分析
  • FPNV 定位矩陣，2024 年
  • 競爭情境分析
  • 戰略分析與建議

公司列表

  • Cardinal Health, Inc.
  • China Isotope & Radiation Corporation
  • Curium Pharma
  • Eckert & Ziegler Radiopharma GmbH
  • GE Healthcare, Inc.
  • Institute of Isotopes Co., Ltd.
  • International Isotopes Inc.
  • Isotope JSC
  • Jubilant DraxImage Inc.
  • Mallinckrodt Pharmaceuticals
  • MEDSNAB LLC
  • Nordion Inc.
  • NorthStar Medical Technologies, LLC
  • NTP Radioisotopes SOC Ltd
  • PDRadiopharma Inc.
  • Shandong Xinhua Pharma
  • Siemens Healthineers AG
  • Telix Pharmaceuticals Limited
  • Yantai Dongcheng Pharmaceutical Group Co. Ltd.
Product Code: MRR-612A4BAA6317

The Sodium Iodide [131I] Market was valued at USD 736.80 million in 2024 and is projected to grow to USD 779.02 million in 2025, with a CAGR of 5.94%, reaching USD 1,041.82 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 736.80 million
Estimated Year [2025] USD 779.02 million
Forecast Year [2030] USD 1,041.82 million
CAGR (%) 5.94%

Sodium Iodide [131I] plays a pivotal role in modern nuclear medicine and industrial applications, marking a turning point in both therapeutic and diagnostic arenas. As the demand for precision interventions grows, this radioactive isotope has become an essential component in radiopharmaceutical formulations and various research initiatives. Recent advancements in technology and regulatory measures have bolstered the reliability of production methods, ensuring that both quality and safety meet the highest international standards.

In today's dynamic environment, stakeholders are witnessing a transformation that blends traditional methodologies with innovative production techniques. The evolution of Sodium Iodide [131I] is reflective of a broader trend within the industry-a shift toward more efficient, safe, and cost-effective practices that support clinical excellence and industrial reliability. In this comprehensive analysis, we explore the multifaceted roles of Sodium Iodide [131I] in diagnostic imaging, radiotherapeutic procedures, and scientific research. Each development underlines the importance of technological integration and regulatory advancements in maintaining the momentum of industry growth.

Moreover, insights into evolving market dynamics suggest that an integrated approach-combining rigorous quality control with progressive research-can dramatically enhance both the production and application of Sodium Iodide [131I]. This introductory overview provides the necessary context for understanding subsequent analyses on market segmentation, regional trends, and strategic company initiatives.

Transformative Shifts in Production, Application, and Market Dynamics

Over the past few years, the market for Sodium Iodide [131I] has experienced transformative shifts that are reshaping its landscape, both in production and application. Companies and institutions have been quick to adopt advanced technologies which enhance the reliability and efficiency of production methods. Innovations in accelerator-based and reactor-based techniques have significantly reduced production times while ensuring that quality and safety remain uncompromised.

The transformation is also evident in the shift towards personalized medicine, where accurate diagnostic imaging and targeted therapy are critical. This evolution has spurred investments in state-of-the-art linear accelerators and hadron accelerators that play a central role in the production process. Concurrently, traditional reactor-based production is undergoing reformation with cyclotron irradiation and uranium fission reactors adapting to newer standards of efficiency and safety.

These shifts are propelled by regulatory frameworks and a growing body of research that continually validates and refines operational protocols. The market is steadily transitioning from conventional practices towards integrated, high-tech solutions that meet both clinical and industrial demands. Today's landscape reflects an era of dynamic change, where collaborative strategies and technological advancements are driving both innovation and competitive advantage in the rapidly evolving field of nuclear medicine and research.

Segmentation Insights across Production, Form, Application, and End-use Industries

Detailed segmentation analysis of the Sodium Iodide [131I] market reveals a complex structure that caters to multiple facets of production, form, application, and end-user industries. First, when looking at the type, the market is distinguished by two primary categories: Pure Sodium Iodide [131I] and Radiopharmaceuticals. This classification underscores the dual nature of the product, serving as both a standalone element and an integral component in diverse therapeutic procedures.

The product is available in various forms including capsule, liquid, and solid, each offering its own set of benefits related to ease of administration, stability, and dosage accuracy. The form of the product is critical in ensuring that it meets the specific requirements of different clinical and research settings. In addition, the production method is another vital segmentation parameter. The industry capitalizes on both accelerator-based production and reactor-based production. Accelerator-based approaches are further refined by applications involving hadron accelerators and linear accelerators, whereas reactor-based production leverages cyclotron irradiation and uranium fission reactors. These innovative methodologies ensure that production is both scalable and adaptable to evolving regulatory standards.

Beyond production techniques, the market finds further segmentation based on application. The industrial segment addresses niche use-cases such as radiation shielding and radiotracer applications. Meanwhile, the medical sector is a primary consumer, particularly in diagnostic imaging, radiopharmaceutical production, and therapeutic procedures. Additionally, research applications in chemical synthesis and nuclear medicine research continue to drive market expansion. Finally, segmentation by end-use industry highlights the broad scope of these products-from academic and research institutions, chemical and biotechnology industries, to healthcare and pharmaceutical sectors, and even nuclear energy plants, thereby reflecting the extensive market reach and diverse application landscape of Sodium Iodide [131I].

Based on Type, market is studied across Pure Sodium Iodide [131I] and Radiopharmaceuticals.

Based on Form, market is studied across Capsule Form, Liquid Form, and Solid Form.

Based on Production Method, market is studied across Accelerator-Based Production and Reactor-Based Production. The Accelerator-Based Production is further studied across Hadron Accelerators and Linear Accelerators. The Reactor-Based Production is further studied across Cyclotron Irradiation and Uranium Fission Reactors.

Based on Application, market is studied across Industrial, Medical, and Research. The Industrial is further studied across Radiation Shielding and Radiotracer Applications. The Medical is further studied across Diagnostic Imaging, Radiopharmaceutical Production, and Therapeutic Procedures. The Research is further studied across Chemical Synthesis and Nuclear Medicine Research.

Based on End-Use Industry, market is studied across Academic & Research Institutions, Chemical & Biotechnology Industries, Healthcare & Pharmaceuticals, and Nuclear Energy Plants.

Regional Market Trends and Emerging Opportunities

The global landscape of the Sodium Iodide [131I] market is characterized by distinctive regional trends shaped by varying economic, regulatory, and technological factors. In the Americas, the market tends to be driven by robust healthcare infrastructure and significant investments in nuclear medicine. This is complemented by a mature industrial base that ensures steady demand for innovative radiopharmaceuticals.

In the Europe, Middle East & Africa region, regulatory frameworks and strategic partnerships play a definitive role in steering market growth. Here, rigorous quality standards and a commitment to technological advancement enhance the production efficiency and broaden the scope of applications. Meanwhile, the Asia-Pacific region is emerging as a key growth nexus, fueled by rapid industrialization, increasing healthcare expenditure, and collaborative research initiatives. The dynamism in this region is largely attributed to progressive regulatory amendments and heightened awareness regarding advanced diagnostic and therapeutic protocols.

Collectively, these regional insights highlight a diverse yet interlinked global market where localized trends coalesce to create a competitive environment. The evolving regulatory landscape, varying degrees of technological adoption, and growing consumer awareness are converging to promote sustainable growth in each region.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Industry Players Driving Market Innovation

Several key companies are instrumental in driving innovation and pushing the boundaries in the Sodium Iodide [131I] market. Industry leaders such as Cardinal Health, Inc. and China Isotope & Radiation Corporation are recognized for their pioneering production techniques and broad market reach. Firms like Curium Pharma and Eckert & Ziegler Radiopharma GmbH continue to innovate in radiopharmaceutical development, ensuring that advanced medical imaging and therapeutic procedures remain within reach for a global patient base.

Other influential players, including GE Healthcare, Inc. and the Institute of Isotopes Co., Ltd., have established themselves by consistently adhering to high industry standards and leveraging advanced technological infrastructures. The contributions of International Isotopes Inc. and Isotope JSC further illustrate the sector's commitment to quality and innovation. Moreover, companies such as Jubilant DraxImage Inc. and Mallinckrodt Pharmaceuticals have broadened the spectrum of applications by integrating cutting-edge research into their product lines.

Additional market influencers like MEDSNAB LLC, Nordion Inc., NorthStar Medical Technologies, LLC, and NTP Radioisotopes SOC Ltd have expanded offerings in both medical and industrial segments. Key collaborations and strategic investments by PDRadiopharma Inc., Shandong Xinhua Pharma, Siemens Healthineers AG, Telix Pharmaceuticals Limited, and Yantai Dongcheng Pharmaceutical Group Co. Ltd. further consolidate the sector's robust network of expertise, thereby driving the overall momentum and fostering a competitive environment in the global market.

The report delves into recent significant developments in the Sodium Iodide [131I] Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., China Isotope & Radiation Corporation, Curium Pharma, Eckert & Ziegler Radiopharma GmbH, GE Healthcare, Inc., Institute of Isotopes Co., Ltd., International Isotopes Inc., Isotope JSC, Jubilant DraxImage Inc., Mallinckrodt Pharmaceuticals, MEDSNAB LLC, Nordion Inc., NorthStar Medical Technologies, LLC, NTP Radioisotopes SOC Ltd, PDRadiopharma Inc., Shandong Xinhua Pharma, Siemens Healthineers AG, Telix Pharmaceuticals Limited, and Yantai Dongcheng Pharmaceutical Group Co. Ltd.. Actionable Recommendations for Strategy and Growth

Industry leaders can unlock significant growth opportunities by implementing actionable strategies that navigate the intricacies of the Sodium Iodide [131I] market. To maintain competitive advantage, companies should consider investing in advanced production technologies that ensure high quality and efficient output, particularly by embracing both accelerator-based and reactor-based methods. These investments will help in optimizing production workflows while reducing operational risks and costs.

In addition, integrating cross-functional collaborations between research institutions, healthcare providers, and industrial partners can foster groundbreaking innovation. Leaders are encouraged to leverage data-driven insights and market segmentation intelligence to tailor products for diverse applications-ranging from diagnostic imaging to industrial radiotracer applications. This multidimensional approach not only enhances product versatility but also addresses the specific needs of different end-user industries including academic, chemical, and pharmaceutical sectors.

Furthermore, capitalizing on emerging regional opportunities is paramount. An agile strategy that adapts to regional regulatory frameworks, consumer preferences, and technology adoption trends can drive market penetration. Companies should also prioritize investments in research and development, focusing on enhancing product efficacy and safety. By cultivating a culture of continuous improvement and innovation, industry leaders can enhance their market positioning, counter competitive pressures, and pave the way for sustainable growth.

Final Thoughts on Market Dynamics and Future Outlook

In summary, the evolution of the Sodium Iodide [131I] market is being driven by technological innovations, evolving regulatory mandates, and comprehensive segmentation strategies that cater to diverse applications. The integration of advanced production methodologies with customized solutions has positioned this market at the forefront of both industrial and medical advancements. Stakeholders now have a clearer roadmap for navigating an increasingly competitive landscape, where adaptability and strategic investments are key.

The concerted efforts by major industry players and regional markets are shaping a future where efficiency, quality, and innovation coalesce to form a robust market framework. This holistic overview not only highlights the current industry dynamics but also sets the stage for future advancements that promise to redefine therapeutic and diagnostic paradigms.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expanding use of sodium iodide [131I] for personalized treatment approaches in oncology, fueling market growth
      • 5.1.1.2. Growing advancements in nuclear medicine and radiopharmaceutical technologies boosting the adoption of sodium iodide [131I] in diagnostics and treatment
      • 5.1.1.3. Increasing need for targeted cancer therapies using sodium iodide [131I] for radioiodine therapy in thyroid cancer treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory challenges and strict safety protocols for the manufacturing and handling of sodium iodide [131I] limiting market growth
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing research and development investments in sodium iodide [131I] to enhance its therapeutic applications and improve patient outcomes
      • 5.1.3.2. Emergence of novel radioactive iodine-based therapies for rare cancers, providing new growth avenues for sodium iodide [131I] market players
    • 5.1.4. Challenges
      • 5.1.4.1. Potential side effects such as thyroid dysfunction and radiation exposure risks associated with sodium iodide [131I] therapy, affecting patient acceptance
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Role of sodium iodide [131I] in radiopharmaceuticals for cancer treatment and diagnostics
    • 5.2.2. End-Use Industry: Significance of sodium iodide [131I] in chemical & biotechnology industries for drug development and molecular imaging
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Sodium Iodide [131I] Market, by Type

  • 6.1. Introduction
  • 6.2. Pure Sodium Iodide [131I]
  • 6.3. Radiopharmaceuticals

7. Sodium Iodide [131I] Market, by Form

  • 7.1. Introduction
  • 7.2. Capsule Form
  • 7.3. Liquid Form
  • 7.4. Solid Form

8. Sodium Iodide [131I] Market, by Production Method

  • 8.1. Introduction
  • 8.2. Accelerator-Based Production
    • 8.2.1. Hadron Accelerators
    • 8.2.2. Linear Accelerators
  • 8.3. Reactor-Based Production
    • 8.3.1. Cyclotron Irradiation
    • 8.3.2. Uranium Fission Reactors

9. Sodium Iodide [131I] Market, by Application

  • 9.1. Introduction
  • 9.2. Industrial
    • 9.2.1. Radiation Shielding
    • 9.2.2. Radiotracer Applications
  • 9.3. Medical
    • 9.3.1. Diagnostic Imaging
    • 9.3.2. Radiopharmaceutical Production
    • 9.3.3. Therapeutic Procedures
  • 9.4. Research
    • 9.4.1. Chemical Synthesis
    • 9.4.2. Nuclear Medicine Research

10. Sodium Iodide [131I] Market, by End-Use Industry

  • 10.1. Introduction
  • 10.2. Academic & Research Institutions
  • 10.3. Chemical & Biotechnology Industries
  • 10.4. Healthcare & Pharmaceuticals
  • 10.5. Nuclear Energy Plants

11. Americas Sodium Iodide [131I] Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Sodium Iodide [131I] Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Sodium Iodide [131I] Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Sanofi ventures into radiopharmaceuticals with EUR 100 million deal for AlphaMedix
    • 14.3.2. Study by Boston University reveals surgical and radioactive iodine treatments significantly lower cardiovascular risks in hyperthyroid patients
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cardinal Health, Inc.
  • 2. China Isotope & Radiation Corporation
  • 3. Curium Pharma
  • 4. Eckert & Ziegler Radiopharma GmbH
  • 5. GE Healthcare, Inc.
  • 6. Institute of Isotopes Co., Ltd.
  • 7. International Isotopes Inc.
  • 8. Isotope JSC
  • 9. Jubilant DraxImage Inc.
  • 10. Mallinckrodt Pharmaceuticals
  • 11. MEDSNAB LLC
  • 12. Nordion Inc.
  • 13. NorthStar Medical Technologies, LLC
  • 14. NTP Radioisotopes SOC Ltd
  • 15. PDRadiopharma Inc.
  • 16. Shandong Xinhua Pharma
  • 17. Siemens Healthineers AG
  • 18. Telix Pharmaceuticals Limited
  • 19. Yantai Dongcheng Pharmaceutical Group Co. Ltd.

LIST OF FIGURES

  • FIGURE 1. SODIUM IODIDE [131I] MARKET MULTI-CURRENCY
  • FIGURE 2. SODIUM IODIDE [131I] MARKET MULTI-LANGUAGE
  • FIGURE 3. SODIUM IODIDE [131I] MARKET RESEARCH PROCESS
  • FIGURE 4. SODIUM IODIDE [131I] MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. SODIUM IODIDE [131I] MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. SODIUM IODIDE [131I] MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SODIUM IODIDE [131I] MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SODIUM IODIDE [131I] MARKET DYNAMICS
  • TABLE 7. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY PURE SODIUM IODIDE [131I], BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY CAPSULE FORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY SOLID FORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY HADRON ACCELERATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY CYCLOTRON IRRADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY URANIUM FISSION REACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RADIATION SHIELDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RADIOTRACER APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY NUCLEAR MEDICINE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY CHEMICAL & BIOTECHNOLOGY INDUSTRIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL SODIUM IODIDE [131I] MARKET SIZE, BY NUCLEAR ENERGY PLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES SODIUM IODIDE [131I] MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 215. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 225. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA SODIUM IODIDE [131I] MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 246. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 248. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 256. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 258. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 266. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 268. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 276. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 278. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 286. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 288. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 296. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 298. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 306. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 308. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 316. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 318. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 326. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 327. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 328. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 329. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY REACTOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 335. NIGERIA SODIUM IODIDE [131I] MARKET SIZE, BY END-USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 336. NORWAY SODIUM IODIDE [131I] MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 337. NORWAY SODIUM IODIDE [131I] MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 338. NORWAY SODIUM IODIDE [131I] MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 339. NORWAY SODIUM IODIDE [131I] MARKET SIZE, BY ACCELERATOR-BASED PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 340. NORWAY SODIUM IODID